BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Australia’s Cyteph Completes Recruitment for Its First-in-Human Trial of CYT-101 in Glioblastoma

Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers, today announced that it has successfully completed...

October 09, 2025 | News

Anasens Partners with MAVAND Solutions to Expand DrugAsens™ Rapid Oral-Fluid Drug Testing Across Europe and Australia

Anasens Inc., a developer of rapid, connected point-of-care detection tools, announced it has signed a distribution agreement with MAVAND Soluti...

October 08, 2025 | News

Kazia Therapeutics Partners with QIMR Berghofer to Develop First-in-Class PD-L1 Degrader NDL2

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, announced an exclusive collaboration and in-licensing agreem...

October 09, 2025 | News

MOLCURE and Boehringer Ingelheim Forge AI-Powered Alliance to Accelerate Antibody Drug Discovery

MOLCURE Inc. announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative an...

October 08, 2025 | News

Wasatch BioLabs Expands Long-Read Sequencing Portfolio with Oxford Nanopore Research Assays

Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read se...

October 07, 2025 | News

RoosterBio and Secretome Therapeutics Achieve Commercial-Scale Production Milestone for Lead Cell Therapy STM-01

RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and...

October 07, 2025 | News

Lonza Expands GMP Portfolio with TheraPEAK® AmpliCell® Cytokines and 293-GT® Medium for Enhanced Cell and Gene Therapy Manufacturing

AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK&r...

October 07, 2025 | News

Australia’s Monash University Launches Boston Hub to Accelerate Global Biotech Partnerships

Top‑50 global university deepens its North America and Europe collaborations to fast‑track drug discovery and health innovation. Monash University, Au...

October 06, 2025 | News

Japan’s Daiichi Sankyo Expands Global R&D Footprint with New Research Institute in San Diego

Daiichi Sankyo (TSE: 4568) has established Daiichi Sankyo Research Institute in San Diego, representing the third research institute established outside of...

October 06, 2025 | News

ExQor Technologies Prepares for Clinical Trials of Regenerative Platform Aiming to Reverse Alzheimer’s Damage

ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine pla...

October 06, 2025 | News

HKUST Uncovers Genetic Variant Driving Alzheimer’s Risk Among Ethnic Chinese

A landmark study conducted by The Hong Kong University of Science and Technology (HKUST) has demonstrated that a genetic variant, TREM2 ...

October 06, 2025 | News

Japan Grants National Reimbursement for MedHub-AI AutocathFFR Marking a Breakthrough in AI-Driven Coronary Physiology

MedHub-AI announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's Autoca...

October 06, 2025 | News

Thermo Fisher’s PPD™ Clinical Research Joins AstraZeneca BioVentureHub for R&D Partnership in Sweden

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, announced a new research and development ...

October 02, 2025 | News

Made Scientific and Syenex Forge Partnership to Transform T Cell Therapy Manufacturing

Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in ...

October 01, 2025 | News

Stay Connected